Top 5 Health Care Stocks That May Fall Off A Cliff This Month
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70.
Here’s the latest list of major overbought players in this sector.
Werewolf Therapeutics, Inc. (NASDAQ: HOWL)
- Werewolf Therapeutics released preliminary results from initial monotherapy dose-escalation cohorts of an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or metastatic solid tumors. The company’s stock has a 52-week high of $4.5690. .
- RSI Value: 77.40
- HOWL Price Action: Shares of Werewolf Therapeutics jumped 47.4% to close at $3.17 on Friday.
Dermata Therapeutics, Inc. (NASDAQ: DRMA)
- Dermata Therapeutics said it has completed start-up activities necessary to support its DMT310 Phase 3 STAR-1 trial ...
Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.